Literature DB >> 2268987

Pharmacokinetic drug interactions with cyclosporin (Part II).

G C Yee1, T R McGuire.   

Abstract

Part I of this article, which appeared in the previous issue of the Journal, considered the potential mechanisms of drug interactions with cyclosporin, and divided the interacting drugs into 2 categories. Drugs that decrease cyclosporin concentrations (e.g. anti-convulsants, rifampicin, etc.) were dealt with first; the authors then moved on to consider the second category, those that increase cyclosporin concentration (macrolide antibiotics, azole antifungal drugs). Part II continues the survey of this category.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2268987     DOI: 10.2165/00003088-199019050-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  178 in total

1.  The effect of ciprofloxacin on antipyrine metabolism.

Authors:  E Ludwig; E Székely; A Csiba; H Graber
Journal:  J Antimicrob Chemother       Date:  1988-07       Impact factor: 5.790

2.  Erythromycin-cyclosporin interaction.

Authors:  J R Godin; I S Sketris; P Belitsky
Journal:  Drug Intell Clin Pharm       Date:  1986-06

3.  Effect of josamycin on plasma cyclosporine levels.

Authors:  C Kreft-Jais; E M Billaud; C Gaudry; J Bedrossian
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Ketoconazole, cyclosporin metabolism, and renal transplantation.

Authors:  R M Ferguson; D E Sutherland; R L Simmons; J S Najarian
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

5.  High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia.

Authors:  J Nemunaitis; H J Deeg; G C Yee
Journal:  Lancet       Date:  1986-09-27       Impact factor: 79.321

6.  Ciclosporin-nicardipine interaction.

Authors:  G Deray; B Aupetit; F Martinez; A Baumelou; A Worcel; M Benhmida; J C Legrand; C Jacobs
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

7.  Effect of bile on cyclosporin absorption in liver transplant patients.

Authors:  M U Mehta; R Venkataramanan; G J Burckart; R J Ptachcinski; B Delamos; S Stachak; D H Van Thiel; S Iwatsuki; T E Starzl
Journal:  Br J Clin Pharmacol       Date:  1988-05       Impact factor: 4.335

8.  Fluconazole is a potent inhibitor of antipyrine metabolism in vivo in mice.

Authors:  I La Delfa; Q M Zhu; Z Mo; T F Blaschke
Journal:  Drug Metab Dispos       Date:  1989 Jan-Feb       Impact factor: 3.922

9.  Effects of nitrendipine on blood pressure and blood ciclosporin A level in patients with posttransplant hypertension.

Authors:  M S Copur; I Tasdemir; C Turgan; U Yasavul; S Caglar
Journal:  Nephron       Date:  1989       Impact factor: 2.847

10.  Co-administration of ciprofloxacin and cyclosporin: lack of evidence for a pharmacokinetic interaction.

Authors:  K K Tan; A K Trull; S Shawket
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

View more
  10 in total

Review 1.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 2.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 3.  Pharmacokinetic considerations in the treatment of inflammatory bowel disease.

Authors:  M Schwab; U Klotz
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 4.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 5.  Omeprazole drug interaction studies.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

6.  The interaction of the diltiazem with oral and intravenous cyclosporine in rats.

Authors:  Sule Kalkan; Mukaddes Gumustekin; Oguz Aygoren; Yesim Tuncok; Ayse Gelal; Hulya Guven
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

Review 7.  Macrolide antibacterials. Drug interactions of clinical significance.

Authors:  N A von Rosensteil; D Adam
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

Review 8.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 9.  Pharmacokinetic drug interactions of macrolides.

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

Review 10.  Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part I.

Authors:  Jeannine S McCune; Meagan J Bemer
Journal:  Clin Pharmacokinet       Date:  2016-05       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.